Crystal structure and evolving SAR considerations of potent, selective benz
ylsulfonamide lactam thrombin inhibitors and related serine protease inhibi
tors have led to the design of novel thrombin inhibitors lag, featuring hyd
rophobic, basic, P-4-alkylaminolactam scaffolds that serve as novel types o
f P-3-P-4 dipeptide mimics. The design, synthesis, and biological activity
of these targets is presented. (C) 1998 Elsevier Science Ltd. All rights re
served.